New research from the Center for Disease Control and Prevention indicates that by early fall 2022, an overwhelming percentage of American adults had antibodies to SARS-CoV-2, the virus that causes COVID-19. According to the study, 96% of 72,748 blood donors aged 16 years and older included in the study had antibodies. Of that group, 23% acquired their immunity from infection alone and 26% from vaccination alone; 48% had hybrid immunity. Researchers say a low prevalence of infection-induced hybrid immunity among older adults reaffirms the importance of this group staying up to date on their vaccination and gaining easy access to antiviral treatments, since they are at increased risk of severe COVID-19. 
 

Related News Articles

Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…